Apple is one tech company serious about health of its users. Now, to push the idea further, it has announced a new collaboration. Johnson & Johnson and Apple have launched Heartline – a first-of-its-kind virtual study to explore if heart health features on Apple devices can improve health outcomes, including reducing the risk of stroke. They are offering eligible US adults (65 years and older) the opportunity to join the clinical study by downloading the Heartline Study app on iPhone. Also Read - Apple Watch credited for saving a teen athlete's life: All you need to know
The aim is to assess whether the Heartline Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation (AFib) — a common form of irregular heart rhythm. aceHeartline is a study that has the potential to fundamentally change our understanding of how digital health tools, like the ECG app and irregular rhythm notification feature on Apple Watch, could lead to earlier detection of AFib,” explained Dr. C. Michael Gibson, Co-Chair of the Heartline Executive Committee and Professor of Medicine, Harvard Medical School and CEO, Baim Institute. Also Read - Apple sued by a New York doctor over atrial fibrillation sensor in Apple Watch
Despite the fact that AFib is a leading cause of stroke, people often do not experience symptoms, making it difficult to diagnose. More than 33 million people worldwide live with AFib and up to 30 per cent don’t even know they have it until a serious cardiovascular event, such as a stroke, occurs. Also Read - Apple Watch Series 5 dominates India's smartwatch list of 2019; Samsung Galaxy Watch 4G follows
aceThrough this important collaboration with Apple, we are pioneering new models that we hope can break down some of the most common barriers to participation in clinical studies,” said Paul Burton, Vice President, Medical Affairs, Internal Medicine, Janssen Scientific Affairs.
Through the app-based approach, the study will enable participants to engage in the study remotely, right from their iPhone and in some cases an Apple Watch, rather than travel to a clinical trial site. aceApple technology is making a meaningful impact on scientific research through the powerful capabilities of iPhone and Apple Watch, all with privacy at the center of the participant experience,” said Myoung Cha, Apple’s Head of Health Strategic Initiatives.
(Written with IANS inputs)